Compounds > 13-ethyl-gon-4-ene-3,17-dione
Page last updated: 2024-11-12

13-ethyl-gon-4-ene-3,17-dione

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

13-ethyl-gon-4-ene-3,17-dione: impurity found in Chinese norgestrel; RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10379264
SCHEMBL ID1422567
MeSH IDM0155781

Synonyms (42)

Synonym
13-ethyl-gon-4-ene-3,17-dione
18a-homo-19-norandrost-4-ene-3,17-dione
18-methyl-19-norandrost-4-ene-3,17-dione
gon-4-ene-3,17-dione, 13-ethyl-
ec 606-833-1
(+)-13-ethylgon-4-ene-3,17-dione
ih07j8f03f ,
unii-ih07j8f03f
13beta-ethylgon-4-ene-3,17-dione
13beta-ethylgon-4-en-3,17-dione
18-methylestr-4-ene-3,17-dione
13-egedo
d-ethyl gonendione
21800-83-9
ethylgonendione
E0921
18-methylestr-4-en-3,17-dione
d-ethylgonendione
AKOS017343453
SCHEMBL1422567
levonorgestrel impurity l (18-methylester-4-ene-3,17-dione)
13beta-ethyl-gon-4-en-3,17-dione
SBLHOJQRZNGHLQ-ATIFRJIPSA-N
13-ethylgon-4-ene-3,17-dione
Q-102817
23477-67-0
18-methyl-estr-4-ene-3,17-dione
13-ethylgon-4-ene-3,17-dione (levodione; 18-methyl-19-norandrost-4-ene-3,17-dione)
dl-ethylgonedione
(8r,9s,10r,13s,14s)-13-ethyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,17-dione
(8r,9s,10r,13s,14s)-13-ethyl-7,8,9,10,11,12,13,14,15,16-decahydro-1h-cyclopenta[a]phenanthrene-3,17(2h,6h)-dione
13-ethyl-gon-4-en-3,17-dione
mfcd08457890
levonorgestrel ep impurity l
levodione; d-ethyl gonendione; 13-ethylgon-4-ene-3,17-dione; (+)-13-?-ethylgon-4-ene-3,17-dione; 18-methyl-19-norandrost-4-ene-3,17-dione; 18-methylestr-4-ene-3,17-dione
T72090
levonorgestrel impurity [ep impurity]
levodione [ep impurity]
(+)-13.beta.-ethylgon-4-ene-3,17-dione
gon-4-ene-3,17-dione, 13-ethyl-, (+/-)-
DTXSID801020560
(3as,3br,9ar,9bs,11as)-11a-ethyl-1h,2h,3h,3ah,3bh,4h,5h,7h,8h,9h,9ah,9bh,10h,11h,11ah-cyclopenta[a]phenanthrene-1,7-dione
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (16.67)18.7374
1990's3 (50.00)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.72

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.72 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.72)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
carbon monoxide
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed). carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.		1.9910carbon oxide;
gas molecular entity;
one-carbon compound		biomarker;
EC 1.9.3.1 (cytochrome c oxidase) inhibitor;
human metabolite;
ligand;
metabolite;
mitochondrial respiratory-chain inhibitor;
mouse metabolite;
neurotoxin;
neurotransmitter;
P450 inhibitor;
probe;
signalling molecule;
vasodilator agent
glucuronic acid
Glucuronic Acid: A sugar acid formed by the oxidation of the C-6 carbon of GLUCOSE. In addition to being a key intermediate metabolite of the uronic acid pathway, glucuronic acid also plays a role in the detoxification of certain drugs and toxins by conjugating with them to form GLUCURONIDES.. D-glucuronic acid : The D-enantiomer of glucuronic acid.. D-glucopyranuronic acid : A D-glucuronic acid in cyclic pyranose form.		1.9810D-glucuronic acidalgal metabolite
betadex
beta-Cyclodextrins: Cyclic GLUCANS consisting of seven (7) glucopyranose units linked by 1,4-glycosidic bonds.		1.9810cyclodextrin
gestodene
Gestodene: synthetic steroid with progestational activity; RN given refers to (17alpha)-isomer		1.9710steroidestrogen
norgestrel
Norgestrel: A synthetic progestational agent with actions similar to those of PROGESTERONE. This racemic or (+-)-form has about half the potency of the levo form (LEVONORGESTREL). Norgestrel is used as a contraceptive, ovulation inhibitor, and for the control of menstrual disorders and endometriosis.		1.9710
ConditionIndicatedRelationship StrengthStudiesTrials